USD27.19
Longevity Peptide Stack Protocol: Clinician Guide 2026 | Meto https://exomapeptides.mx/imgr/product-images/catalogo/8ddcee51-ab4d-4449-920f-97a02fbd6e58.webp?pv=20260712-uniforme&width=560&height=560&resize=contain&quality=70&format=webp mg:20mg X 5pk BPC-157 5 mg Comparing These Four Peptides | Compound | Primary Target | Main Effect | |---|---|---| | Sermorelin | GHRH Receptor | Stimulates endogenous GH release | | CJC-1295 | GHRH Receptor | Sustained GH stimulation | | Ipamorelin | Ghrelin Receptor (GHS-R1a) | Triggers GH secretion | | IGF-1 LR3 | IGF-1 Receptor | Direct tissue-level IGF signaling | For a deeper dive into the specific compounds available, see our Peptide Therapy Education page, which catalogs 23 active peptide compounds with full mechanism-of-action references
USD27.19
USD25.47
USD22.00
USD26.65
USD27.74
USD29.06
USD26.43
USD28.08
USD29.59
USD24.86
USD20.26
USD28.99
USD25.23
USD27.94
Refer to previously supplied evidence when it remains relevant. Ask for confirmation when new instructions replace earlier guidance.
Check the relevant terms before changing the named recipient afterward. Keep any agreed arrangement in writing for future reference.
Ask for clarification when you are unsure about exact wording. Use the acknowledged details as the practical reference for next steps.